The mission of OPER provides a center of support for prescribers and dispensers to better promote professional education, informed clinical decision-making, best practices and innovation so that Maryland patients experience optimal access, efficacy and safety in connection with controlled substances.
The Office of Controlled Substances Administration and the Prescription Drug Monitoring Program (PDMP) are merged as the Office of Provider Engagement and Regulation (OPER). The OPER continues the functions of both OCSA and PDMP and maintains all mandated requirements and restrictions related to data access.
Deputy Director - Prescription Drug Monitoring Program
Deputy Director - Office of Controlled Substances Administration
Click on the images below to access websites.